Medical Spa MD is a community of 28,000+ plastic surgeons, dermatologists, & aesthetic physicians practicing cosmetic medicine worldwide. FREE Medical Spa Deals for Clinicians

About   |   Advertise   |   Press   |   Contact

2nd MD - Boarded US physicians work from anywhere.
Medical Justice
Relentlessly protecting physicians from frivolous lawsuits.

More control of your income, career, and lifestyle as a physician.

Medical Spa MD is a world-wide physician community for clinicians in skin clinics, laser centers and medspas with thousands of physician members around the world. By using this site you agree to our terms of service and fine print.

« ASAPS 2009 Statistics Are In | Main | Idiot Ass Augmentations Hospitlize Six In New Jersey »

Allergan - Botox Cosmetic 

No need to shed tears for Allergan with a market cap of nearly $18 billion last week.

Allergan Inc. Chief Executive David Pyott is guarded about 2010 as the drug maker faces competition, uncertain spending on its medical cosmetics and a relatively quiet year for product launches.

“It’s sensible to remain conservative in our forecast given there are still a number of challenges to be accounted for,” Pyott said. “You need to think about 2010 potentially being the most challenging of the coming years.”

For most of the last decade, Allergan played offense.

The Irvine-based drug maker was fueled by its $3 billion 2006 buy of Santa Barbara medical cosmetic maker Inamed Corp. and big product rollouts, including Botox Cosmetic in 2002 and eyelash growth drug Latisse at the end of 2008.

This year, Allergan is in more of a defensive mode, with worries about a slow economic recovery and its impact on medical cosmetics spending, expected generic competition for a key eye drug and the first full year of sales for Botox’s only rival.

Allergan gave a guarded outlook for the current quarter and 2010 earlier this month. The forecast was cautious even by the standards of Pyott, known for underpromising and overdelivering.

The company said it expected a profit of $174.3 million to $180.4 million for the first quarter, well below the $186 million analysts had been looking for on average.

The drug maker projected first-quarter product sales (slightly less than total sales) of $1.06 billion to $1.1 billion. On average, analysts had been expecting sales to come in at $1.11 billion.

For all of 2010, Allergan forecasts a profit of $944.9 million to $963.3 million, in line with analysts’ average expectation of $960.2 million.

2010 product sales are pegged at $4.55 billion to $4.75 billion, below the $4.78 billion Wall Street had been forecasting.

The 2010 outlook “didn’t have quite the upside to our forecast that we hoped,” said Gary Nachman, an analyst with Boston-based Leerink Swann LLC, in a research note.

Allergan’s shares briefly slumped after its forecast before rebounding, which “strongly suggests investors expect better results than those Allergan has projected,” Aaron Gal, an analyst for New York-based Sanford C. Bernstein & Co., told Reuters.

Allergan had a market value of nearly $18 billion last week.

Via Orange County Business Journal

Reader Comments (3)

what are the benefits of this cosmetic...

Quad bike

03.15 | Unregistered CommenterQuad bike

It would be interesting to see what effect Dysport had on Botox in the last year. Anybody have stats on that?

I would say by the way Medicis markets Dysport not much if any slump. We don't use Dysport, don't have to since nobody asks for the stuff.

I was hoping they would give Allergan a run for their money so maybe pricing would come down. No such luck.

03.18 | Unregistered CommenterSBJ

PostPost a New Comment

Enter your information below to add a new comment.
Author Email (optional):
Author URL (optional):
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

Join Medical Spa MD

Medical Spa MD

A community of dermatologists, plastic surgeons, laser clinics, & skin clinics world wide.

Medical Spa MD is a world-wide community of physicians and clinicians practicing cosmetic medicine. Please read our Terms of Service, Advertising Terms and Privacy Policy.

Copyright © 2011. All rights reserved.